107 related articles for article (PubMed ID: 3512118)
1. Mutagenicity of the mercapturic acid and other S-containing derivatives of hexachloro-1,3-butadiene.
Wild D; Schütz S; Reichert D
Carcinogenesis; 1986 Mar; 7(3):431-4. PubMed ID: 3512118
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity of hexachloro-1,3-butadiene and its S-conjugates in the Ames test--role of activation by the mercapturic acid pathway in its nephrocarcinogenicity.
Vamvakas S; Kordowich FJ; Dekant W; Neudecker T; Henschler D
Carcinogenesis; 1988 Jun; 9(6):907-10. PubMed ID: 3286031
[TBL] [Abstract][Full Text] [Related]
3. Mercapturic acid formation is an activation and intermediary step in the metabolism of hexachlorobutadiene.
Reichert D; Schütz S
Biochem Pharmacol; 1986 Apr; 35(8):1271-5. PubMed ID: 3516155
[TBL] [Abstract][Full Text] [Related]
4. Stereo- and regioselective conjugation of S-halovinyl mercapturic acid sulfoxides by glutathione S-transferases.
Rosner E; Müller M; Dekant W
Chem Res Toxicol; 1998 Jan; 11(1):12-8. PubMed ID: 9477221
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of hexachloro-1,3-butadiene in mice: in vivo and in vitro evidence for activation by glutathione conjugation.
Dekant W; Schrenk D; Vamvakas S; Henschler D
Xenobiotica; 1988 Jul; 18(7):803-16. PubMed ID: 3176519
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of hexachlorobutadiene, perchlorobutenoic acid and perchlorobutenoic acid chloride.
Reichert D; Neudecker T; Schütz S
Mutat Res; 1984; 137(2-3):89-93. PubMed ID: 6381998
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic transformation of mercapturic acids derived from halogenated alkenes to reactive and mutagenic intermediates.
Vamvakas S; Dekant W; Berthold K; Schmidt S; Wild D; Henschler D
Biochem Pharmacol; 1987 Sep; 36(17):2741-8. PubMed ID: 3307787
[TBL] [Abstract][Full Text] [Related]
8. Deacetylation and further metabolism of the mercapturic acid of hexachloro-1,3-butadiene by rat kidney cytosol in vitro.
Pratt IS; Lock EA
Arch Toxicol; 1988; 62(5):341-5. PubMed ID: 3242443
[TBL] [Abstract][Full Text] [Related]
9. Intranephron distribution of cysteine S-conjugate beta-lyase activity and its implication for hexachloro-1,3-butadiene-induced nephrotoxicity in rats.
Kim HS; Cha SH; Abraham DG; Cooper AJ; Endou H
Arch Toxicol; 1997; 71(3):131-41. PubMed ID: 9049049
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the role of glutathione conjugation in the protection afforded by anethol dithiolthione against hexachloro-1,3-butadiene-induced nephrotoxicity.
Bouthillier L; Charbonneau M; Brodeur J
Toxicol Appl Pharmacol; 1996 Jul; 139(1):177-85. PubMed ID: 8685901
[TBL] [Abstract][Full Text] [Related]
11. The metabolism and disposition of hexachloro-1:3-butadiene in the rat and its relevance to nephrotoxicity.
Nash JA; King LJ; Lock EA; Green T
Toxicol Appl Pharmacol; 1984 Mar; 73(1):124-37. PubMed ID: 6710510
[TBL] [Abstract][Full Text] [Related]
12. Bacterial beta-lyase mediated cleavage and mutagenicity of cysteine conjugates derived from the nephrocarcinogenic alkenes trichloroethylene, tetrachloroethylene and hexachlorobutadiene.
Dekant W; Vamvakas S; Berthold K; Schmidt S; Wild D; Henschler D
Chem Biol Interact; 1986 Oct; 60(1):31-45. PubMed ID: 3536138
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation, excretion, and nephrotoxicity of the hexachlorobutadiene metabolite (E)-N-acetyl-S-(1,2,3,4, 4-pentachlorobutadienyl)-L-cysteine sulfoxide.
Birner G; Werner M; Rosner E; Mehler C; Dekant W
Chem Res Toxicol; 1998 Jul; 11(7):750-7. PubMed ID: 9671537
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow and renal injury associated with haloalkene cysteine conjugates in calves.
Lock EA; Sani Y; Moore RB; Finkelstein MB; Anders MW; Seawright AA
Arch Toxicol; 1996; 70(10):607-19. PubMed ID: 8870953
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and excretion of S-conjugates derived from hexachlorobutadiene in the isolated perfused rat kidney.
Schrenk D; Dekant W; Henschler D
Mol Pharmacol; 1988 Sep; 34(3):407-12. PubMed ID: 3419428
[TBL] [Abstract][Full Text] [Related]
16. Effect of the organic acid transport inhibitor probenecid on renal cortical uptake and proximal tubular toxicity of hexachloro-1,3-butadiene and its conjugates.
Lock EA; Ishmael J
Toxicol Appl Pharmacol; 1985 Oct; 81(1):32-42. PubMed ID: 4049419
[TBL] [Abstract][Full Text] [Related]
17. Bioactivation of hexachlorobutadiene by glutathione conjugation.
Dekant W; Vamvakas S; Anders MW
Food Chem Toxicol; 1990 Apr; 28(4):285-93. PubMed ID: 2192968
[TBL] [Abstract][Full Text] [Related]
18. The formation of both a mono- and a bis-substituted glutathione conjugate of hexachlorobutadiene by isolated hepatocytes and following in vivo administration to the rat.
Jones TW; Gerdes RG; Ormstad K; Orrenius S
Chem Biol Interact; 1985 Dec; 56(2-3):251-67. PubMed ID: 4075451
[TBL] [Abstract][Full Text] [Related]
19. Mutagenicity of the glutathione and cysteine S-conjugates of the haloalkenes 1,1,2-trichloro-3,3,3-trifluoro-1-propene and trichlorofluoroethene in the Ames test in comparison with the tetrachloroethene-analogues.
Dreessen B; Westphal G; Bünger J; Hallier E; Müller M
Mutat Res; 2003 Aug; 539(1-2):157-66. PubMed ID: 12948824
[TBL] [Abstract][Full Text] [Related]
20. Properties of the microsomal and cytosolic glutathione transferases involved in hexachloro-1:3-butadiene conjugation.
Oesch F; Wolf CR
Biochem Pharmacol; 1989 Jan; 38(2):353-9. PubMed ID: 2914021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
